Next Up

3D Cell Culture Symposium

02 December 2021 |

Online: GMT (UTC+0)

02 December 2021

Online: GMT (UTC+0)

Incorporating key trends and innovative technologies to accelerate the adoption of 3D models in preclinical research via advanced development, validation and application strategies.

02 Mar 2022
Wed, 02 March 2022

Cell Therapy Analytics Symposium

Jun 2022
June 2022

Gene Therapy Development & Manufacturing: In-Person

Engage in scientific discussions on the latest tools and technologies for advancing cell therapy analytical development.

Oct 2022
October 2022

Cell UK: In-Person

Highlights

In 2020, the global cell culture market was valued at 3.4 billion USD, and between 2021-2025, it is poised to grow by 13 billion USD at a CAGR of 10.67%.
Insight Article
What will the future of cell culture process development look like? We delve into 3 of the most promising approaches to achieve Next Generation advances for cell and gene therapy.
By Tia Byer |
17 November 2021
Cell Line Development & Engineering
Commentary
By Tia Byer |
01 Nov 2021
Cell Therapy Development
Insight Article
By Tia Byer |
22 Oct 2021
Cell & Gene Therapy Manufacturing

Insights

Insight Article
What will the future of cell culture process development look like? We delve into 3 of the most promising approaches to achieve Next Generation advances for cell and gene therapy.
17 November 2021
Commentary
What does the future of the vaccine look like? Tony D’Amore and Yan-Ping Yang of Sanofi Pasteur take us through the ever-evolving vaccine development and manufacturing landscape.
01 November 2021
Insight Article
What are the key challenges facing gene therapy commercialisation today, and how can the industry best overcome them? This Insight Article delves into the top 3 strategies needed to bring the next generation of advanced therapeutics to the market and get ahead of the game.
22 October 2021
Commentary
Arun Srivastava of the University of Florida’s takes us through the history of the AAV Vector development for Human Gene Therapy and analyses the critical role of his institution’s Division of Cellular and Molecular Therapy in the optimising and discovery of Next Generation AAVs.
07 October 2021

[sponsor section - bespoke content]

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Cell

Submit your details to receive the monthly newsletter & to be kept up to date about relevant events, monthly discussion groups and portal membership offers. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.